S'abonner

Nicotine poisoning-related deaths in Seoul Capital Area, Korea, 2014–2021 - 15/08/22

Doi : 10.1016/j.toxac.2022.06.203 
Minji Kang , Sungmin Moon, Byungjoo Kim, So-Hyun Kim, Junghyun Kim, Hyeyoung Choi, Sanggil Choe
 Forensic toxicology lab, National forensic service, Seoul, Republic of Korea 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Aim

For last 8 years, fatal nicotine intoxication cases have occurred constantly in Korea. Even though nicotine has been utilized for long time as a cigarette form, high concentration of liquid nicotine for e-cigarette became easily accessible after its global marketing in 2015. As a discrepancy of blood nicotine concentration between reported fatal cases and our postmortem cases was observed, we reviewed fatal nicotine poisoning cases in Seoul capital area from 2014 to 2021.

Method

All decedents in Seoul capital area from 2014 to 2021 whose cause of death was fatal nicotine poisoning were retrospectively studied; the route of administration included injection or ingestion of e-liquid, and attachment of nicotine transdermal patches. The autopsies were carried out at Seoul Institute of National Forensic Service (NFS), and heart bloods and/or femoral vein bloods were submitted for toxicological analysis. As a substitute of blood sample, liver tissues were collected and analyzed. The concentrations of nicotine from biological samples were quantitated with liquid chromatography-tandem mass spectrometry (LC-MS/MS) after sample preparation. The concentrations of nicotine were evaluated with several parameters; method of administration, co-administered drug or alcohol etc.

Results

Seventy-one fatal cases of nicotine were identified and analyzed. The average blood concentration of nicotine was 42mg/L in heart blood (range: 0.69–250, n=37) and 18mg/L in femoral vein blood (range: 0.33–130, n=64). The average nicotine concentration in liver tissue was 150mg/kg (range: 1.6–610, n=6). In a fatal case of poisoning with 70 nicotine transdermal patches, heart and femoral vein blood concentration of nicotine were 7.7mg/L and 3.3mg/L, respectively. The average femoral vein blood concentration was 19mg/L in fatal nicotine cases with no other drug or alcohol co-administered (range: 1.27–87, n=24), whereas that was 17mg/L in fatal nicotine cases with drug(s) and/or alcohol co-administered (range: 0.33–130, n=40). As a sub-group, the average femoral vein blood concentration was 11mg/L in the cases with alcohol but no other drug co-administered (range: 0.33–58mg/L, n=16).

Conclusion

In analysis of nicotine poisoning cases, the results should be interpreted with caution. Even though average value was presented here, the lethal blood concentration range was wide; from less than 1mg/L to more than 100mg/L. The tolerance at a certain concentration might be different whether the exposed person was a habitual smoker or a non-smoker. Also, co-administration of alcohol or drugs may increase the risk of death at lower nicotine concentration.

Le texte complet de cet article est disponible en PDF.

Plan


© 2022  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 34 - N° 3S

P. S124-S125 - septembre 2022 Retour au numéro
Article précédent Article précédent
  • Contents of cannabinoids in commercial hemp seed oil capsules in Korea
  • Yeji Jung, Sora An, Junghyun Moon, Miri Han, Sangki Lee, Heesun Chung
| Article suivant Article suivant
  • Regional changes in stimulant drug use during COVID-19 pandemic in Finland: A wastewater study
  • Aino Kankaanpää, Teemu Gunnar

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.